Literature DB >> 31173997

Liquid chromatography-tandem mass spectrometry to assess the pharmacokinetics and tissue distribution of withaferin A in rats.

Fan Wang1, Jinyi Zhao2, Juan Bai2, Kai Gao2, Dongxiao Cui2, Yuan Chen3, Ying Song4, Yanyan Jia5, Aidong Wen6.   

Abstract

Withaferin A (WA) is a bioactive ingredient in the medicinal Indian herb Withania somnifera (WS). In this study, we developed a rapid and accurate Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS) method to determine the concentration of WA in rat plasma and tissue following intravenous (i.v., 4.5 mg/kg) and oral (i.g, 0.5, 1.5 and 4.5 mg/kg) administration. WA was isolated on a Hypurity C18 (50 × 4.6 mm, 5 μm) column by isocratic elution at a flow rate of 0.5 mL/min using acetonitrile and water as the mobile phase (35:65, v/v). The retention time was 4 min. Ethyl acetate containing 5% ascorbic acid was used as the extraction solvent through simple liquid-liquid extraction (LLE). Withanolide A (WLD) was used as the internal standard (IS). Quantification was performed through multiple reaction monitoring (MRM) modes of m/z 471.1 → 281 for WA and m/z 488.1 → 263 for IS in the positive-ion mode. This revealed no significant effects of the WA concentration or administration route on the T1/2. The distribution of WA in the various tissues was in the order: stomach > heart > lung > kidney > small intestinal > spleen > following i.g administration (4.5 mg/kg). These data provide valuable insight into the clinical parameters of WA.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  HPLC-MS/MS; Pharmacokinetic; Tissue distribution; Withaferin A

Mesh:

Substances:

Year:  2019        PMID: 31173997     DOI: 10.1016/j.jchromb.2019.05.016

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

Review 1.  A Comprehensive Review and Perspective on Anticancer Mechanisms of Withaferin A in Breast Cancer.

Authors:  Eun-Ryeong Hahm; Su-Hyeong Kim; Krishna B Singh; Kamayani Singh; Shivendra V Singh
Journal:  Cancer Prev Res (Phila)       Date:  2020-07-29

Review 2.  Tackling Chronic Inflammation with Withanolide Phytochemicals-A Withaferin a Perspective.

Authors:  Emilie Logie; Wim Vanden Berghe
Journal:  Antioxidants (Basel)       Date:  2020-11-10

3.  RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells.

Authors:  Eun-Ryeong Hahm; Su-Hyeong Kim; Krishna B Singh; Shivendra V Singh
Journal:  Mol Carcinog       Date:  2020-11-04       Impact factor: 4.784

4.  Withaferin A Exerts Preventive Effect on Liver Fibrosis through Oxidative Stress Inhibition in a Sirtuin 3-Dependent Manner.

Authors:  Jingya Gu; Chang Chen; Jue Wang; Tingting Chen; Wenjuan Yao; Tingdong Yan; Zhaoguo Liu
Journal:  Oxid Med Cell Longev       Date:  2020-09-24       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.